What is the truth about proton pump inhibitors?
- PMID: 33109942
- DOI: 10.1097/MOO.0000000000000663
What is the truth about proton pump inhibitors?
Abstract
Purpose of review: This review explores the recent evidence and established scientific literature surrounding proton pump inhibitors in the context of laryngology.
Recent findings: Proton pump inhibitors are often associated with gastroenterology; however, they also have a place in laryngology. Several laryngopharyngeal disorders are treated with proton pump inhibitors, though limited evidence regarding effectiveness, dosing and length of treatment exists. With the recent influx of articles reporting possible adverse effects of proton pump inhibitors, the appropriate prescribing of them has come under scrutiny. These reported risks include cancer, stroke, myocardial infarction, kidney disease and cognitive decline. It should be noted though that many of these studies by nature, are fraught with potential confounding. Regardless, clinicians ought to be aware of any risks associated with treatment regimens and prescribe the optimal dosage and duration.
Summary: Proton pump inhibitor treatment should be dose-appropriate and for a limited duration. Concerning potential adverse effects, the limitations of retrospective cohort studies must be taken into consideration when reviewing the evidence.
References
-
- Gracie DJ, Ford AC. The possible risks of proton pump inhibitors. Med J Aust 2016; 205:292–293.
-
- Hollingworth S, Duncan EL, Martin JH. Marked increase in proton pump inhibitors use in Australia. Pharmacoepidemiol Drug Saf 2010; 19:1019–1024.
-
- Pratt NL, Kalisch Ellett LM, Sluggett JK, et al. Use of proton pump inhibitors among older Australians: national quality improvement programmes have led to sustained practice change. Int J Qual Health Care 2017; 29:75–82.
-
- Schubert ML. Adverse effects of proton pump inhibitors: fact or fake news? Curr Opin Gastroenterol 2018; 34:451–457.
-
- Elias E, Targownik LE. The clinician's guide to proton pump inhibitor related adverse events. Drugs 2019; 79:715–731.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials